Preclinical Studies: Apelin RA patch

Anodyne to Present Preclinical Muscle Regeneration Data at PODD 2025 in Boston, MA 

OCT 24 2025

​​

​​

Preclinical Studies: ANN-102 for Sarcopenia

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy

JUNE 9 2025

​​

​​

JPM 2025

Meet Anodyne at JPM Healthcare Week 2025

JANUARY 12 2025

​​

​​

Preclinical Studies: Once-weekly GLP1 patch

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs

DECEMBER 19 2024

​

Business Wire

​​

Successful GLP-1 Data

Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MA

OCTOBER 25 2024

​​

Board of Directors

Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors.

FEBRUARY 6 2023

​

Business Wire